Balda AG has acquired C. Brewer Company
Balda AG (Balda) has acquired C. Brewer Company in Anaheim, California.
The C. Brewer Company, a family-owned business, specializes in precision injection-molded plastics and associated molds, in particular for customers from the medical and optical industries as well as from the automotive and electronics sectors.
Germany-based Balda develops and manufactures high quality plastic systems for medical appliances as well as complete electronic products for communication and entertainment. The Balda Medical segment in Bad Oeynhausen develops and produces plastic solutions for the medical technology, pharmaceutical and diagnosis markets.
This acquisition is part of Balda’s buy-and-build strategy for its medical segment. Through this acquisition, Balda extends its presence in the strategically important US market and particularly strengthens its medical business.
Oaklins' team in Germany advised Balda on this acquisition.


Talk to the deal team
Related deals
Cerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreEast Metal has been acquired by management and private investors
The Latvia-based metalworking company East Metal has been acquired from its former Danish owner, East Metal Holding, through a management buy-out (MBO) by a group of private investors, the current owners of Valpro, in partnership with the local management team. Financing for the transaction was provided by Signet Bank.
Learn moreQuantum Base Holdings plc has completed its official admission to AIM
Quantum Base began trading on the London Stock Exchange’s AIM market under the ticker QUBE following a US$6.4 million (£4.8 million) fundraising round. The company develops Q-ID tags, a quantum-based authentication technology designed to prevent counterfeiting by leveraging atomic-level randomness. Proceeds from the listing will fund product development and commercial expansion, including new operational and commercial hires.
Learn more